How To Use HCPCS Code A9700

HCPCS code A9700 describes the supply of injectable contrast material for use in echocardiography, per study. This code is used to identify the specific service or supply provided by healthcare providers during echocardiography procedures. In this article, we will explore the details of HCPCS code A9700, including its official description, procedure, when to use it, billing guidelines, historical information, Medicare and insurance coverage, and provide examples of when this code should be billed.

1. What is HCPCS A9700?

HCPCS code A9700 is used to identify the supply of injectable contrast material for use in echocardiography, per study. This code specifically refers to the contrast material used during echocardiography procedures. Echocardiography is a diagnostic imaging technique that uses ultrasound waves to create images of the heart. The contrast material helps enhance the visibility of certain structures or abnormalities during the procedure.

2. Official Description

The official description of HCPCS code A9700 is “Supply of injectable contrast material for use in echocardiography, per study.” This description accurately reflects the purpose of this code, which is to identify the supply of contrast material used during echocardiography procedures.

3. Procedure

1. The healthcare provider prepares the patient for the echocardiography procedure.
2. The provider administers the injectable contrast material to the patient.
3. The provider performs the echocardiography procedure using ultrasound waves.
4. The provider interprets the results of the echocardiography and documents the findings.

It is important for healthcare providers to follow the appropriate protocols and guidelines for administering the contrast material and performing the echocardiography procedure.

4. When to use HCPCS code A9700

HCPCS code A9700 should be used when healthcare providers supply injectable contrast material specifically for use in echocardiography procedures. This code is applicable when performing echocardiography studies and using contrast material to enhance the visibility of certain structures or abnormalities in the heart.

5. Billing Guidelines and Documentation Requirements

When billing for HCPCS code A9700, healthcare providers need to document the administration of the injectable contrast material during the echocardiography procedure. They should also include the details of the study and any relevant findings in the medical documentation. Proper documentation is essential for accurate billing and reimbursement.

6. Historical Information and Code Maintenance

HCPCS code A9700 was added to the Healthcare Common Procedure Coding System on January 01, 2001. Since its addition, there have been no maintenance actions taken for this code, as indicated by the action code N, which means no maintenance for this code. This suggests that the code has remained unchanged since its inception.

7. Medicare and Insurance Coverage

HCPCS code A9700 is covered by Medicare and other insurance carriers. The pricing indicator code 57 indicates that the service or supply is priced by other carriers. The multiple pricing indicator code A signifies that the code is not applicable as HCPCS priced under one methodology. Healthcare providers should refer to the Medicare Carriers Manual Reference Section Number 15360 for specific guidelines and instructions regarding coverage and reimbursement for this code.

8. Examples

Here are five examples of when HCPCS code A9700 should be billed:

1. A patient undergoes an echocardiography study to assess the function of their heart valves. The healthcare provider administers injectable contrast material during the procedure to enhance the visualization of the valves.
2. A patient with a suspected cardiac abnormality undergoes an echocardiography study. The provider uses injectable contrast material to improve the visibility of the abnormality and accurately diagnose the condition.
3. A patient with a history of heart disease requires a follow-up echocardiography study. The provider administers injectable contrast material to assess any changes or progression of the disease.
4. A patient undergoes a stress echocardiography study to evaluate their heart’s response to exercise. The provider uses injectable contrast material to enhance the visualization of the heart during the stress test.
5. A patient with a known heart defect undergoes an echocardiography study to monitor the condition. The provider administers injectable contrast material to assess the defect’s progression and plan appropriate treatment.